Antinuclear antibody profile in UCD line 200 chickens: a model for progressive systemic sclerosis.

Institute for General and Experimental Pathology, University of Innsbruck Medical School, Austria.
International Archives of Allergy and Immunology (Impact Factor: 2.43). 02/1993; 100(4):307-13. DOI: 10.1159/000236430
Source: PubMed

ABSTRACT The fully blown disease of human progressive systemic sclerosis (PSS, scleroderma) is serologically associated with the emergence of several types of autoantibodies, some of them regarded as more specific for scleroderma (e.g. Scl-70, anti-centromere) and some common also to other connective tissue diseases (e.g. anti-ssDNA). Since most patients suffering from PSS are not under medical control until clinical manifestations are fully established, only scarce data are available on the dynamics and clinical significance of autoantibodies in the very early stages of this systemic fibrotic disease. The University of California at Davis line 200 (UCD 200) of chickens spontaneously develop a PSS-like disorder with an acute inflammatory stage around 60 days after hatching, leading to fibrosis with fast progression. In order to address a possible correlation between the occurrence and titer of autoantibodies and the initial disease activity, we have chronologically investigated the presence and titer of autoantibodies directed against several human nuclear antigens in this animal strain. In UCD-200 chickens, we found a progressive increase in autoantibodies to histones, to ssDNA and--to a lesser degree--dsDNA with peaks at the age of 60 and 120 days, to poly(I) and poly(G) with a peak at 120 days and an elevation in anti-cardiolipin antibodies. Total immunoglobulin concentrations, anti-Ro, anti-La and anti-Sm showed no significant differences as compared to negative results in healthy normal controls. Our data reveal parallels in the antinuclear antibody (ANA) spectrum between UCD-200 chickens and human autoimmune collagen diseases, but do not reflect the typical ANA spectrum found in the foudroyant form of diffuse scleroderma.(ABSTRACT TRUNCATED AT 250 WORDS)

1 Follower
  • [Show abstract] [Hide abstract]
    ABSTRACT: In the present study, we report the successful use of ultrasound device as a real-time, in situ diagnostic tool for monitoring the crystallization progress of zeolite A from homogeneous colloidal solutions with the composition 0.4 Na2O : 10 SiO2 : 1.4 Al2O3 : 16 (TMA)2O: 650 H2O. The results demonstrate that there exist good correlation between the crystallisation progress of zeolite A in terms of yield and the attenuated ultrasonic signal. It is also revealed that the kinetic information like activation energy of crystallisation reaction could be easily calculated from the measured ultrasonic signals data. In the studied case, activation energy of Ca. 30 kJ/mol was obtained.
    Studies in surface science and catalysis 01/2007; 170:480-486. DOI:10.1016/S0167-2991(07)80880-9
  • [Show abstract] [Hide abstract]
    ABSTRACT: The effect of the hydroxyl radical on polyguanylic acid [poly(G)] was investigated with regard to progressive increase of autoantibodies against it in systemic lupus erythematosus (SLE) and progressive systemic sclerosis (PSS). Rabbits immunized with both native and ROS-poly(G) induced high titre antibodies. Immune IgG exhibited a high degree of specificity towards the immunogen, reiterated visually by a gel retardation assay. The induced antibodies showed a wide range of cross-reactivity with various synthetic polynucleotides exhibiting B-, A-, and allied conformations. The specificity of induced antibodies resembled the diverse binding characteristics of lupus anti-DNA autoantibodies. Moreover, sera from scleroderma patients showed binding to native and ROS-poly(G). SLE and PSS autoantibodies showed preferential recognition of ROS-poly(G) over native poly(G). These results demonstrate that the hydroxyl modified guanine residues in DNA and RNA can induce circulating SLE and PSS autoantibodies.
    Journal of Autoimmunity 09/1998; 11(4-11):371-378. DOI:10.1006/jaut.1998.0208 · 7.02 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Systemic sclerosis is a disease characterized by vascular and skin changes associated with activation of fibroblasts and increased synthesis of matrix components. These abnormalities lead to fibrosis and impaired function of internal organs such as the lung, kidney, and gastrointestinal tract. Recent evidence suggests that although activation of cells in and around the blood vessels and in the skin occurs in systemic sclerosis, injury to the vascular endothelium and defective apoptosis of skin fibroblasts may also contribute to disease. The purpose of this review is to discuss these findings in the context of the pathophysiology of systemic sclerosis. This review highlights concepts and recent findings relating to apoptosis of vascular endothelium and skin fibroblasts. Important paradigms of fibroblast cell death in wound healing and keloid formation are discussed. Recent observations describing resistance of systemic sclerosis fibroblasts to Fas-mediated apoptosis and activation of the antiapoptotic protein kinase, Akt, are mentioned as possible contributors to fibroblast selection in this disease. Improved understanding of how death and survival signals affect vascular endothelial cells and skin and visceral fibroblasts will lead to new approaches to therapy.
    Current Opinion in Rheumatology 11/2003; 15(6):756-60. DOI:10.1097/00002281-200311000-00012 · 5.07 Impact Factor